CIPO Patents = 2

Forward Citations = 5

Loading Chart...

5 inventors (with patents filed for the assignee):

Dalia Megiddo (4 out of 16 patents)

Raj Mehra (2 out of 2 patents)

Timothy Whitaker (1 out of 1 patent)

4. Warren Wasiewski (1 out of 1 patent)

5. Gopal Krishna (1 out of 1 patent)

6 patents: Sort by Forward Citations

1. 12440457 - Methods of treating suicidality (2025-10-14),

2. 12370204 - Trehalose formulations and uses thereof (2025-07-29),

3. 12239733 - Treatment of protein aggregation myopathic and neurodegenerative diseases by parenteral administration of trehalose (2025-03-04),

4. 10869831 - Treatment of protein aggregation myopathic and neurodegenerative diseases by parenteral administration of trehalose (2020-12-22),

5. 10751353 - Compositions and methods for treating an aggregation disease or disorder (2020-08-25),

6. 10493023 - Treatment of protein aggregation myopathic and neurodegenerative diseases by parenteral administration of trehalose (2019-12-03),

Company Overview

Seelos Therapeutics, Inc. is a biopharmaceutical company focused on developing innovative therapies for central nervous system disorders. With a robust pipeline of clinical-stage assets, Seelos is dedicated to addressing unmet medical needs in conditions such as depression, anxiety, and neurodegenerative diseases. The company's proprietary technologies enable the advancement of novel treatment strategies aimed at improving patient outcomes. Seelos is committed to scientific excellence and collaboration, driving forward its mission to transform the care of patients with debilitating conditions.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

6 Patents

#1,027 in New York, NY

#2,695 in New York

#44,981 in US

New York, NY, United States of America

Seelos Therapeutics, Inc.

Forward Citations = 5

5 inventors:

Dalia Megiddo (4 out of 16 patents)

Raj Mehra (2 out of 2 patents)

Timothy Whitaker (1 out of 1 patent)

4. Warren Wasiewski (1 out of 1 patent)

5. Gopal Krishna (1 out of 1 patent)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Seelos Therapeutics, Inc.. Retrieved from https://idiyas.com/company/seelos-therapeutics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

2 patents (CIPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]